Brainstorm Cell Therapeutics, Inc. (BCLI)
0.9302
-0.07
(-6.98%)
USD |
OTCM |
Oct 02, 16:00
Brainstorm Cell Therapeutics 1 Year Total Returns (Daily) : 29.19% for Oct. 2, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 02, 2026 | 29.19% |
| October 01, 2026 | 40.17% |
| September 30, 2026 | 34.25% |
| September 29, 2026 | 31.71% |
| September 28, 2026 | 31.83% |
| September 25, 2026 | 38.57% |
| September 24, 2026 | 35.68% |
| September 23, 2026 | 26.10% |
| September 22, 2026 | 34.78% |
| September 21, 2026 | 24.37% |
| September 18, 2026 | 34.33% |
| September 17, 2026 | 42.03% |
| September 16, 2026 | 37.89% |
| September 15, 2026 | 47.27% |
| September 14, 2026 | 50.89% |
| September 11, 2026 | 52.01% |
| September 10, 2026 | 39.76% |
| September 09, 2026 | 28.25% |
| September 08, 2026 | 41.35% |
| September 04, 2026 | 37.80% |
| September 03, 2026 | 38.96% |
| September 02, 2026 | 63.68% |
| September 01, 2026 | 53.62% |
| August 31, 2026 | 40.13% |
| August 28, 2026 | 53.88% |
| Date | Value |
|---|---|
| August 27, 2026 | 63.77% |
| August 26, 2026 | 71.43% |
| August 25, 2026 | 55.76% |
| August 24, 2026 | 54.99% |
| August 21, 2026 | 55.31% |
| August 20, 2026 | 70.97% |
| August 19, 2026 | 88.76% |
| August 18, 2026 | 127.4% |
| August 17, 2026 | 73.53% |
| August 14, 2026 | 64.04% |
| August 13, 2026 | 24.39% |
| August 12, 2026 | 37.15% |
| August 11, 2026 | 41.43% |
| August 10, 2026 | 36.23% |
| August 07, 2026 | 24.02% |
| August 06, 2026 | 31.15% |
| August 05, 2026 | 33.80% |
| August 04, 2026 | 11.96% |
| August 03, 2026 | 17.91% |
| July 31, 2026 | 26.76% |
| July 30, 2026 | 26.62% |
| July 29, 2026 | 21.03% |
| July 28, 2026 | 24.93% |
| July 27, 2026 | 30.08% |
| July 24, 2026 | 39.13% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| NovelStem International Corp. | -65.70% |
| Summit Therapeutics, Inc. | -19.72% |
| Kezar Life Sciences, Inc. | 87.40% |
| Protara Therapeutics, Inc. | -36.02% |
| Clene, Inc. | -49.06% |